Type: Package Package: savvyr Title: Survival Analysis for AdVerse Events with VarYing Follow-Up Times Version: 0.1.2 Date: 2025-04-15 Authors@R: c( person("Thomas", "Kuenzel", email = "thomas.kuenzel@roche.com", role = c("aut", "cre")), person("Kaspar", "Rufibach", email = "kaspar.rufibach@roche.com", role = "aut"), person("Regina", "Stegherr", email = "regina.stegherr@uni-ulm.de", role = "aut"), person("Daniel", "Sabanés Bové", email = "daniel@rconis.com", role = "aut"), person("F. Hoffmann-La Roche AG", role = c("cph", "fnd")), person("Universität Ulm", role = c("cph", "fnd")) ) Description: The SAVVY (Survival Analysis for AdVerse Events with VarYing Follow-Up Times) project is a consortium of academic and pharmaceutical industry partners that aims to improve the analyses of adverse event (AE) data in clinical trials through the use of survival techniques appropriately dealing with varying follow-up times and competing events, see Stegherr, Schmoor, Beyersmann, et al. (2021) . Although statistical methodologies have advanced, in AE analyses often the incidence proportion, the incidence density or a non-parametric Kaplan-Meier estimator are used, which either ignore censoring or competing events. This package contains functions to easily conduct the proposed improved AE analyses. License: Apache License 2.0 URL: https://openpharma.github.io/savvyr/ BugReports: https://github.com/openpharma/savvyr/issues Depends: R (>= 4.0) Imports: checkmate, etm, Rdpack Suggests: kableExtra, knitr, rmarkdown, testthat (>= 3.0) Config/Needs/documentation: roxytypes, roxylint RdMacros: Rdpack VignetteBuilder: knitr Encoding: UTF-8 Language: en-US RoxygenNote: 7.3.2 Repository: https://openpharma.r-universe.dev Date/Publication: 2025-05-07 15:18:04 UTC RemoteUrl: https://github.com/openpharma/savvyr RemoteRef: HEAD RemoteSha: 6b1eff7f8a9c60ed43ad759bcee42402bf685d6e NeedsCompilation: no Packaged: 2026-06-20 07:58:25 UTC; root Author: Thomas Kuenzel [aut, cre], Kaspar Rufibach [aut], Regina Stegherr [aut], Daniel Sabanés Bové [aut], F. Hoffmann-La Roche AG [cph, fnd], Universität Ulm [cph, fnd] Maintainer: Thomas Kuenzel